Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep762 | Pituitary and Neuroendocrinology | ECE2023

Challenges in the management of prolactinomas: A case of partial resistance to high-dose cabergoline in a young male with an invasive giant prolactinoma

Cheţan Larisa-Nicoleta , Vladan Andreea , Hortopan Dan , Gobej Ionut , Radian Serban , Poiana Catalina

Background: Giant prolactinomas are rare pituitary tumours larger than >40 mm in diameter, representing 2–3% of prolactin secreting tumours. Management is challenging especially in male patients, due to resistance to dopamine agonists (DA).Methods: Clinical, hormonal and imaging evaluation and follow-upAim: To describe a case of partially resistant giant prolactinoma in a young male patientCase repor...

ea0050p213 | Diabetes and Cardiovascular | SFEBES2017

Genomic instability in type 2 diabetes mellitus patients from Yucatan, Mexico

Pacheco-Pantoja Elda , May-Kim Sherlin , Lopez-Rivas Victor , Manjarrez-Martin Aimee , Che-Correa Erick , Baeza-Gamboa Beatriz

Background: Genomic damage plays an important role in the pathogenesis of Type 2 Diabetes Mellitus (T2DM) and its complications. This instability increases with impaired metabolic control, and is aggravated by the presence of advance glycation-end products (AGEs) causing more cell damage. The aim of this study was to analyse the presence of genomic instability in patients with T2DM and its association with the levels of AGEs, namely glycated h...

ea0050p213 | Diabetes and Cardiovascular | SFEBES2017

Genomic instability in type 2 diabetes mellitus patients from Yucatan, Mexico

Pacheco-Pantoja Elda , May-Kim Sherlin , Lopez-Rivas Victor , Manjarrez-Martin Aimee , Che-Correa Erick , Baeza-Gamboa Beatriz

Background: Genomic damage plays an important role in the pathogenesis of Type 2 Diabetes Mellitus (T2DM) and its complications. This instability increases with impaired metabolic control, and is aggravated by the presence of advance glycation-end products (AGEs) causing more cell damage. The aim of this study was to analyse the presence of genomic instability in patients with T2DM and its association with the levels of AGEs, namely glycated h...

ea0063p1045 | Interdisciplinary Endocrinology 2 | ECE2019

Clinical audit of immune related adverse events of the endocrine system with checkpoint inhibitor therapies – adopting a new algorithm for routine endocrine monitoring

Anderson Cian , Sheehan David , Ronan Karine , Othman Elly Hanis Che , McKenna Susan , McDermott Ray , Westrup Jennifer , Griffin Margaret

Background: Immune related adverse events (iRAEs) of the endocrine system are commonly recognised in Checkpoint Inhibitor Therapy treatment with current research suggesting clinically significant endocrinopathies occur in 10%. As the use of these drugs continues to rise, so too does the importance of routine endocrine monitoring in order to avoid potentially life-threatening adverse-events.Aims: To establish the frequency, severity, management and outcom...

ea0026p457 | Thyroid cancer | ECE2011

Reversine, an anti-cancer candidate, induces cell cycle arrest and apoptosis in human thyroid cancer

Lee Ying-Ray , Hua Shih-Che , Chen Shu-Hsin , Lu Chieh-Hsiang , Yu Hui-I , Chen Hau-Ren , Chang Tien-Chun

Thyroid cancer is the most prevalent cancer among endocrine malignancies. Surgical resection combined with radioactive iodine therapy has been proved effective in treating differentiated thyroid cancer, including papillary and follicular thyroid cancers. However, regarding metastatic poorly differentiated or anaplastic thyroid cancers, there have been no available effective treatment modalities. The genomic instability, such as chromosome aneupolidy, represents a hallmark of s...